Should you buy Pasqal stock, the French quantum computing gem?

Pasqal is the first French quantum computing company to go public. Backed by a Nobel Prize winner and breakthrough technology, the French star is listed on the Nasdaq under the ticker PSQL. But is it a smart move to buy Pasqal stock in 2026? The article Should you buy Pasqal stock, the French quantum computing gem? appeared first on Cryptoast.

Pasqal’s Nasdaq debut, under the ticker PSQL, marks a historic turning point for French deeptech. By becoming the first French company in the quantum sector to enter the public markets via a SPAC merger, the firm is solidifying its international ambitions while sparking debate over France’s technological sovereignty. Backed by a prestigious scientific pedigree, including Nobel Prize in Physics laureate Alain Aspect, the group stands out for its proprietary neutral atom technology, which operates at room temperature—a stark contrast to the energy-intensive cryogenic systems used by competitors.

Operationally, the company demonstrates rare stability for the sector, with a fleet of seven processors deployed and three more currently in production. Its impressive client roster, featuring industrial giants such as EDF, Thales, and the IBM Quantum Network, serves as a testament to its concrete commercial adoption. This strong footing allowed Pasqal to raise nearly $360 million during its IPO, bringing its valuation to approximately $2 billion. These funds are strategic for scaling up industrial production and advancing the development of its Atomiq Lab.

Despite these strengths, the investment carries significant structural risks. With $19.4 million in 2025 revenue, the current valuation represents roughly 100 times revenue—a ratio that highlights the speculative nature of the stock. Investors must also account for potential share dilution resulting from convertible financing and warrants integrated into the deal. Furthermore, competition with industry titans like Google, IBM, and IonQ remains fierce, and the long-term competitive advantage of neutral atom technology must still be proven to justify such high multiples.

The challenge for Pasqal now lies in its ability to translate technological promise into tangible profitability within a volatile market environment. While shares are currently only available via standard securities accounts, the company is preparing for a secondary listing on Euronext Paris—a highly anticipated move that would facilitate access for European investors. For now, the stock is primarily aimed at bold investors willing to bet on the emergence of a European quantum champion within a rapidly evolving global ecosystem.